Clinical trials
Cardiomyopathies trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 2 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 7 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 4 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 12 |
| Unknown status | 7 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Withdrawn | 1 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 8 |
| Alnylam Pharmaceuticals | 6 |
| Abbott Medical Devices | 2 |
| Ancora Heart, Inc. | 2 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Intellia Therapeutics | 2 |
| University Hospital, Caen | 2 |
| University Hospital, Toulouse | 2 |
| Adverum Biotechnologies, Inc. | 1 |
| Bayer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 51 |
| Heart Failure | 12 |
| Amyloidosis | 9 |
| Heart Diseases | 5 |
| Alzheimer Disease | 3 |
| Amyloid Neuropathies, Familial | 3 |
| Amyloidosis, Familial | 3 |
| Cardiomyopathy, Dilated | 3 |
| Myocarditis | 3 |
| Atrial Fibrillation | 2 |
Trials
Showing 26 to 50 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.